Skip to main content
OpenTrials

Clinical trial condition

Pyruvate Kinase Deficiency

Explore clinical trials studying Pyruvate Kinase Deficiency. Study availability and eligibility vary by location and protocol.

12 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Pyruvate Kinase Deficiency trial results

Enrolling by Invitation

A Study to Provide Continued Access to Mitapivat for Participants Who Previously Completed an Agios-Sponsored Mitapivat Study

NCT05777993

Conditions
Anemia, Anemia, Hemolytic, Hematologic Diseases, +3 more
Locations
  • McMaster Centre for Transfusion Medicine McMaster University Hamilton, Ontario, Canada
  • Tohoku University Hospital Sendai, Miyagi, Japan
  • Kyoto Katsura Hospital Kyoto, Japan
  • Toho University - Omori Medical Center Ōta-ku, Japan
View Trial Details
Completed

A Study of AG-348 in Adult Participants With Pyruvate Kinase (PK) Deficiency

NCT02476916

Conditions
Anemia, Anemia, Hemolytic, Hematologic Diseases, +3 more
Locations
  • Stanford University Palo Alto, California, United States
  • Boston Children's Hospital Boston, Massachusetts, United States
  • Wayne State University School of Medicine - Children's Hospital of Michigan Detroit, Michigan, United States
  • New York Presbyterian Hospital- Weil Cornell Medical College New York, United States
View all 13 locations
View Trial Details
Completed

Extension Study of AG-348 in Adult Participants With Pyruvate Kinase Deficiency Previously Enrolled in AG-348-006 or AG348-C-007

NCT03853798

Conditions
Pyruvate Kinase Deficiency, Pyruvate Kinase Deficiency of Red Cells
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • UCSF Benioff Children's Hospital, Oakland Oakland, California, United States
  • Emory-Children's Center Atlanta, Georgia, United States
  • Indiana Hemophilia & Thrombosis Center Inc. Indianapolis, Indiana, United States
View all 42 locations
View Trial Details
Completed

Gene Therapy for Pyruvate Kinase Deficiency (PKD)

NCT04105166

Conditions
Anemia, Anemia, Hemolytic, Hematologic Diseases, +3 more
Locations
  • Stanford University Stanford, California, United States
  • Hospital Infantil Universitario Niño Jesús Madrid, Spain
  • Hospital Universitario Fundación Jiménez Díaz Madrid, Spain
View Trial Details
Completed

A Study to Evaluate Efficacy and Safety of AG-348 in Not Regularly Transfused Adult Participants With Pyruvate Kinase Deficiency (PKD)

NCT03548220

Conditions
Anemia, Anemia, Hemolytic, Hematologic Diseases, +3 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Emory University Atlanta, Georgia, United States
  • Indiana Hemophilia and Thrombosis Center Indianapolis, Indiana, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View all 46 locations
View Trial Details
Completed

A Study Evaluating the Efficacy and Safety of AG-348 in Regularly Transfused Adult Participants With Pyruvate Kinase Deficiency (PKD)

NCT03559699

Conditions
Anemia, Anemia, Hemolytic, Hematologic Diseases, +3 more
Locations
  • UCSF Benioff Children's Hospital Oakland, California, United States
  • Emory University Atlanta, Georgia, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Seattle Cancer Care Alliance Seattle, Washington, United States
View all 19 locations
View Trial Details

Related conditions